Both Eli Lilly LLY and Merck MRK are major players in the U.S. pharmaceutical industry, developing and commercializing ...

The healthcare sector, including managed-care firms and drug powerhouses, is vastly underperforming the S&P 500 index. Here ...

Pharmaceutical heavyweights Merck & Co. Inc. (NYSE: MRK) and Eli Lilly and Company (NYSE: LLY) are getting a lot of attention after outperforming the market by a mile in 2018. Both stocks have ...

Merck’s stock has declined by close to 10% since early February after the WHO declared the coronavirus a global health emergency, while Eli Lilly stock has fared much better and gained 15%. The ...

Eli Lilly (NYSE: LLY) and Merck (NYSE: MRK) are both among the largest biopharmaceutical businesses in the world, but their growth prospects aren't exactly the same. Nonetheless, the pair handily ...

According to TipRanks.com, Wright is a 5-star analyst with an average return of 12.3% and a 61.9% success rate. Wright covers the Healthcare sector, focusing on stocks such as Phibro Animal Health, ...

Few things can jolt a pharmaceutical company's shares like positive results from highly anticipated clinical trials. Even so, ...

2. Merck Is More Profitable . Eli Lilly’s operating margin of 24.5% over the last twelve-month period is slightly lower than 33.0% for Merck. This compares with 21.8% and 18.7% figures seen in ...

Sales of Covid-19 drugs fueled year-over-year revenue growth for Merck MRK 0.13 % increase; green up pointing triangle & Co. Inc. and Eli Lilly LLY-2.71 % decrease; red down pointing triangle & Co ...

Pharmaceutical heavyweights Merck & Co. Inc. (MRK-0.26%) and Eli Lilly and Company (LLY 3.78%) are getting a lot of attention after outperforming the market by a mile in 2018. Both stocks have ...

Pharmaceutical heavyweights Merck & Co. Inc. (NYSE: MRK) and Eli Lilly and Company (NYSE: LLY) are getting a lot of attention after outperforming the market by a mile in 2018. Both stocks have ...